|
|
Bolstering Emerging Companies
For emerging biotechs (e-Bios), the gap between “great potential” and “great potential realized” can seem almost insurmountable. Clinical development hiccups. Commercialization challenges. Financing obstacles. At every step, there seem to be more questions than answers. And for the industry segment that’s leading the way in new compound development, answers to those questions have far-reaching implications.
At NovaQuest, we’ve established a dedicated team with a single dedication: To help e-Bios find the expertise, infrastructure and resources to fully pursue their ambitions. That is, to answer the questions that vex you most.
Our rich clinical, operations and regulatory expertise ideally positions us to provide a practical, powerful infrastructure for virtual drug development. So, our strategic value can be easily found in clinical and operational expertise that leads products through every phase of development.
Our experience in evaluating products and bringing them to market makes us an ideal resource for VCs and other life science investors considering new opportunities. More importantly, we know how to inject capital at just the right time in just the right way. So whether you need mezzanine or portfolio-based financing, we can help you secure the capital that keeps your product moving, while you maintain more control and value.
|